MDMA-assisted therapy and clinical research
Research, medicine approval and permission to prescribe are different questions.
Sources checked November 14, 2026. Author and independent clinical review pending. Check your country’s regulator for current rules.
Does a clinical trial mean a treatment is approved?
No. Trials study interventions under a research protocol and informed-consent process; participation is not a guarantee of benefit. [1]
What do the regulatory sources show?
The US FDA’s August 2024 complete response letter did not approve the submitted MDMA capsule application in its then-current form. That letter is a dated decision, not a substitute for checking later regulatory actions. [2]
Australia has a narrow pathway for certain authorised psychiatrists to prescribe MDMA for PTSD, subject to the applicable approvals and supervision requirements. It is not general legalisation or ordinary retail access. [3]
Canada describes case-by-case Special Access Program requests for serious or life-threatening conditions, with important restrictions. Special access is not general product approval. [4]
How do clinical trials work?
A protocol defines eligibility, study procedures, monitoring and outcomes. Informed consent explains what is involved and known risks; volunteers can ask questions before deciding. Some trials use comparison groups or random assignment. Read the study-specific information rather than assuming all trials follow the same design. [1]
What should I ask a study team?
- What is being studied, and what is still uncertain?
- Who oversees the study and monitors adverse effects?
- What screening, follow-up, costs and withdrawal arrangements apply?
These are questions for informed consent, not a recommendation to seek MDMA or join a particular trial. [1]